OMRON (6645) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jun, 2025Executive summary
Q3 consolidated sales remained flat year-over-year, but operating and net income rose sharply due to improved gross margins and efficient fixed cost management.
Net sales for the nine months ended December 31, 2024, declined 4.7% year-over-year to JPY579.7 billion, while operating income rose 35.1% to JPY35.9 billion, driven by improved gross margin and cost reductions from structural reforms.
Net income attributable to shareholders decreased 8.5% year-over-year to JPY7.2 billion, impacted by one-time restructuring expenses of JPY21.2 billion under the NEXT2025 program.
IAB (Industrial Automation) performance recovered, while HCB (Healthcare) and DMB (Device & Module Solutions) continued to face sluggish demand.
Comprehensive income fell 33.5% year-over-year to JPY23.3 billion.
Financial highlights
Q3 net sales: ¥205.1bn (-1.1% YoY); gross profit: ¥91.7bn (+6.5% YoY, margin 44.7%); operating income: ¥16.7bn (+181.6% YoY, margin 8.1%); net income: ¥10.5bn (+493.8% YoY).
Q1–Q3 cumulative net sales: ¥579.7bn (-4.7% YoY); operating income: ¥35.9bn (+35.1% YoY); net income: ¥7.2bn (-8.5% YoY, impacted by one-time structural reform expenses of ¥21.2bn).
Full-year forecast: net sales ¥805.0bn (-1.7% YoY); operating income ¥54.0bn (+57.2% YoY); net income ¥12.5bn (+54.2% YoY); EPS ¥63.48.
Gross profit margin improved to 45.1% from 42.5% year-over-year.
Cash and cash equivalents at period end were JPY136.9 billion; free cash flow improved to negative JPY10.3 billion from negative JPY47.2 billion year-over-year.
Outlook and guidance
Full-year operating and net income forecasts revised upward, reflecting improved fixed cost plans and higher IAB expectations.
Dividend per share (DPS) guidance for year-end at ¥52, full-year at ¥104, unchanged from initial guidance.
Full-year forecast includes approximately JPY22.0 billion in one-time restructuring expenses.
Demand recovery expected to remain moderate; semiconductor industry strong, but EV and China markets remain weak.
Actual results may differ materially from projections due to market, currency, and restructuring uncertainties.
Latest events from OMRON
- Revenue and net sales up YoY, net income nearly doubled, and full-year guidance raised.6645
Q3 20265 Feb 2026 - Sales up 5%, profit guidance raised as automation and data outperform, healthcare lags.6645
Q2 202619 Nov 2025 - Net income rebounded to ¥6.8bn as automation and device growth offset healthcare weakness.6645
Q1 20266 Aug 2025 - Sales and profit fell sharply on restructuring costs, but full-year outlook is maintained.6645
Q1 202513 Jun 2025 - Full-year profit guidance raised and dividends maintained despite lower sales and restructuring costs.6645
Q2 202513 Jun 2025 - Profits surged on margin gains; FY2025/26 outlook cautious amid tariff risks.6645
Q4 20259 Jun 2025